United Therapeutics CEO trust sells 9,500 shares
A pre-arranged trading plan adopted November 7, 2025, runs until the earlier of exercise of 1,734,410 options or December 31, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
United Therapeutics Corp. (UTHR) Chairperson & CEO Martine A. Rothblatt’s family trust exercised options for 9,500 common shares at $117.76 per share on November 6, 2026, then sold 9,500 resulting shares that day in nine transactions. The exercise and sales were under a pre-arranged Rule 10b5-1 trading plan adopted November 7, 2025. The plan continues until the earlier of exercise of 1,734,410 stock options, all expiring March 15, 2027, or December 31, 2026.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,500 shares ($4.24M approx. pre-tax spread)
Exercise and Sale
11 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
9,500 shs ($5.36M)
Approx. gross sale proceeds
$5.36M
Approx. exercise cost
$1.12M
Approx. pre-tax spread
$4.24M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F15, F16 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $117.76 | $1.12M |
| Sale | Common Stock F1, F3, F2 | 109 | $560.7894 | $61K |
| Sale | Common Stock F1, F4, F2 | 2,005 | $561.7985 | $1.13M |
| Sale | Common Stock F1, F5, F2 | 1,136 | $562.8685 | $639K |
| Sale | Common Stock F1, F6, F2 | 870 | $563.8519 | $491K |
| Sale | Common Stock F1, F7, F2 | 1,776 | $564.9856 | $1.00M |
| Sale | Common Stock F1, F8, F2 | 1,742 | $565.8481 | $986K |
| Sale | Common Stock F1, F9, F2 | 1,021 | $566.83 | $579K |
| Sale | Common Stock F1, F10, F2 | 761 | $567.6381 | $432K |
| Sale | Common Stock F1, F11, F2 | 80 | $568.68 | $45K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock F12 | -- | -- | -- |
| Holding | Common Stock F13 | -- | -- | -- |
| Holding | Common Stock F14 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 71,910 options (Indirect, by Trust);
Common Stock — 628,049 shares (Indirect, by Trust);
Common Stock — 40,513 shares (Direct);
Common Stock — 166 shares (Indirect, by Spouse)
Footnotes (16)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10. This transaction was executed in multiple trades at prices ranging from $567.38 to $568.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $568.38 to $568.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F13. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F14. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F15. These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F16. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $560.23 to $561.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $561.29 to $562.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $562.33 to $563.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $563.36 to $564.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $564.36 to $565.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $565.36 to $566.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $566.38 to $567.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Stock options exercised: 9,500 options
Exercise price: $117.76 per share
Common shares sold: 9,500 shares
+3 more
6 metrics
Stock options exercised
9,500 options
November 6, 2026
Exercise price
$117.76 per share
Options exercised November 6, 2026
Common shares sold
9,500 shares
Nine transactions on November 6, 2026
Weighted average sale price for 109 shares
$560.7894 per share
Sale transaction on November 6, 2026
Weighted average sale price for 80 shares
$568.6800 per share
Sale transaction on November 6, 2026
Plan exercise threshold
1,734,410 stock options
The plan continues until the earlier of this exercise threshold or December 31, 2026
Key Terms
pre-arranged 10b5-1 trading plan, weighted average price, stock options
3 terms
pre-arranged 10b5-1 trading plan regulatory
"pre-arranged 10b5-1 trading plan adopted by the reporting person"
weighted average price financial
"the price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
stock options financial
"This exercise of stock options and sale of the resulting shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When does Martine A. Rothblatt’s UTHR trading plan end?
The pre-arranged plan adopted November 7, 2025, continues until the earlier of exercise of 1,734,410 stock options, all of which expire March 15, 2027, or December 31, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
